Skip to Content

Chlorpheniramine / Methscopolamine / Phenylephrine Dosage

Applies to the following strength(s): 2 mg-0.625 mg-10 mg/5 mL ; 8 mg-2.5 mg-20 mg ; 2 mg-1.25 mg-10 mg/5 mL ; 2 mg-1.25 mg-10 mg ; 4 mg-1.25 mg-10 mg ; 12 mg-2.5 mg-20 mg ; ages 12 years and older ; 2 mg-0.75 mg-8 mg/5 mL ; 2 mg-0.75 mg-10 mg/5 mL ; 4 mg-1.25 mg-10 mg/ 5 mL ; 8 mg-1.25 mg-20 mg ; 2 mg-1.5 mg-10 mg/5 mL ; 8 mg-2.5 mg-25 mg ; 2 mg-1.25 mg-15 mg ; 2 mg-1.5 mg-10 mg ; ages 6 years and older ; 8 mg-2.5 mg-40 mg ; 12 mg-2 mg-40 mg

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Nasal Congestion

Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release:
1 tablet orally twice a day, not to exceed 2 doses per day.

chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day.

chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release:
chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening.

chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening.

Liquid:
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily.

Usual Adult Dose for Rhinitis

Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release:
1 tablet orally twice a day, not to exceed 2 doses per day.

chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day.

chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release:
chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening.

chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening.

Liquid:
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily.

Usual Pediatric Dose for Nasal Congestion

12 yrs and older:
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release:
1 tablet orally twice a day, not to exceed 2 doses per day.

chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day.

chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release:
chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening.

chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening.

Liquid:
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily.

6 yrs to 11 yrs:
Liquid:
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 2.5 to 5 mL orally every 4 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.

chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL, extended release 2.5 to 5 mL orally every 12 hours daily.

Chew tab:
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-15 mg chewable: 1 tablet orally every 4 hours not to exceed 4 tablets per day.

Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release:
1/2 tablet orally twice daily, not to exceed 2 doses per day.

chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1/2 to 1 tablet orally every 12 hours, not to exceed 2 tablets per day.

chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1/2 to 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1/2 to 1 tablet orally in the evening.

Usual Pediatric Dose for Rhinitis

12 yrs and older:
Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-20 mg oral tablet, extended release:
1 tablet orally twice a day, not to exceed 2 doses per day.

chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg oral tablet or chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1 to 2 tablets orally every 12 hours, not to exceed 4 tablets per day.

chlorpheniramine/methscopolamine/PE varying strength oral tablet, extended release:
chlorpheniramine/methscopolamine/PE 2.5 mg-40 mg extended release: 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-10 mg extended release: 1 tablet orally in the evening.

chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1 or 2 tablets orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1 or 2 tablets orally in the evening.

Liquid:
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL extended release: 5 to 10 mL orally every 12 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.625 mg-10 mg/5 mL oral syrup 10 mL orally every 4-6 hours, not to exceed 4 doses per day.
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg/5 mL oral syrup: 5 to 10 mL orally every 3-4 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 10 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 5 to 10 mL orally every 3 or 4 hours daily.

6 yrs to 11 yrs:
Liquid:
chlorpheniramine/methscopolamine/PE 4 mg-1.25 mg-10 mg/5 mL: 2.5 to 5 mL orally every 4 hours daily.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-8 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.
chlorpheniramine/methscopolamine/PE 2 mg-0.75 mg-10 mg/5 mL: 5 mL orally every 4 to 6 hours daily not to exceed 4 doses in 24 hours.

chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg/5 mL, extended release 2.5 to 5 mL orally every 12 hours daily.

Chew tab:
chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-15 mg chewable: 1 tablet orally every 4 hours not to exceed 4 tablets per day.

Tablets:
chlorpheniramine/methscopolamine/PE 8 mg-1.25 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-25 mg, extended release or
chlorpheniramine/methscopolamine/PE 8 mg-2.5 mg-40 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2.5 mg-20 mg, extended release or
chlorpheniramine/methscopolamine/PE 12 mg-2 mg-40 mg, extended release:
1/2 tablet orally twice daily, not to exceed 2 doses per day.

chlorpheniramine/methscopolamine/PE 2 mg-1.25 mg-10 mg oral tablet, chewable: 1/2 to 1 tablet orally every 12 hours, not to exceed 2 tablets per day.

chlorpheniramine/methscopolamine/PE ages 6 years and older oral tablet, extended release
chlorpheniramine/methscopolamine/PE 2 mg-1.5 mg-10 mg extended release: 1/2 to 1 tablet orally in the morning and
chlorpheniramine/methscopolamine/PE 2 mg--1.5 mg extended release: 1/2 to 1 tablet orally in the evening.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dialysis

Data not available

Hide